| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 778,000 | 918,000 | 1,782,400 | 1,464,200 | | Cost of Revenue | 720,200 | 816,600 | 2,656,700 | 1,616,300 | | | Gross Profit | 57,800 | 101,400 | (874,300) | (152,100) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 144,100 | 150,200 | 202,000 | 217,800 | | Non Recurring |
-
|
-
| 79,400 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (86,300) | (48,800) | (1,155,700) | (369,900) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,700 | 13,800 | 7,600 | 3,100 | | Earnings Before Interest And Taxes | (79,600) | (35,000) | (1,148,100) | (366,800) | | Interest Expense | 23,400 | 26,300 | 17,100 | 12,300 | | Income Before Tax | (103,000) | (61,300) | (1,165,200) | (379,100) | | Income Tax Expense | 5,500 | 1,300 | (365,400) | 20,200 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (108,500) | (62,600) | (799,800) | (399,300) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (108,500) | (62,600) | (799,800) | (399,300) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($108,500) | ($62,600) | ($799,800) | ($399,300) |
|
0.45% Nasdaq 
0.20%
Income Statement
